Evidence map›Paper›PMID 42343284›Full record

ArticleBMC primary care2026

Biopsychosocial factors associated with health-related quality of life in long COVID: a matched case-control study in primary care.

David Lerma-Irureta, Elsa Presa-Gutiérrez, Fátima Méndez-López, Carmen Vicente-García, Isabel Blasco-González, Rosa Magallón-Botaya

Abstract read
In one paragraph

Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David Lerma-IruretaDepartment of Medicine, Psychiatry and Dermatology, University of Zaragoza, Saragossa, Spain. dlerma@iisaragon.es.
Elsa Presa-GutiérrezInstituto de Investigación Sanitaria Aragón, Saragossa, Spain.
Fátima Méndez-LópezInstituto de Investigación Sanitaria Aragón, Saragossa, Spain.
Carmen Vicente-GarcíaDepartment of Medicine, Psychiatry and Dermatology, University of Zaragoza, Saragossa, Spain.
Isabel Blasco-GonzálezCS Monzón, SALUD, Huesca, Spain.
Rosa Magallón-BotayaDepartment of Medicine, Psychiatry and Dermatology, University of Zaragoza, Saragossa, Spain.

Funding

Instituto de Salud Carlos III PI22/01070
6 · The paper itself

Abstract

backgroundLong COVID is associated with persistent symptoms, functional impairment, and reduced health-related quality of life (HRQoL), but the factors most strongly associated with poorer HRQoL remain incompletely characterized. This study compared adults with long COVID and recovered controls and identified variables independently associated with worse HRQoL.

methodsWe conducted a case-control analysis of the ARALONGCOV 2022 dataset including 170 adults with prior COVID-19: 85 with long COVID and 85 recovered controls without persistent symptoms. HRQoL was assessed with the 12-item Short Form Health Survey (SF-12) total score. Additional measures included depressive symptoms (Patient Health Questionnaire-9, PHQ-9), fatigue severity (Fatigue Severity Scale, FSS), sleep quality (Pittsburgh Sleep Quality Index, PSQI), pain catastrophizing, post-COVID functional status (PCFS), physical activity, and distance completed during the six-minute walk test (6MWT-D). Between-group comparisons used Mann-Whitney U tests for continuous variables and chi-squared or Fisher exact tests for categorical variables. Univariable and multivariable linear regression models were fitted within long COVID cases to identify factors independently associated with SF-12 total score.

resultsCompared with recovered controls, participants with long COVID had markedly worse HRQoL (median SF-12 28.75 [IQR 21.25-39.17] vs 73.96 [62.81-77.50]; p < 0.001), more depressive symptoms (PHQ-9: 12.00 [7.00-18.00] vs 2.00 [0.00-6.00]; p < 0.001), greater fatigue (FSS: 57.00 [50.00-62.00] vs 13.00 [9.00-33.00]; p < 0.001), worse sleep quality (PSQI: 14.00 [9.00-16.00] vs 6.00 [3.00-11.00]; p < 0.001), and shorter 6MWT-D (481 [406-560] m vs 556 [491-609] m; p < 0.001). Long COVID cases were also less frequently employed (38.8% vs 81.2%; p < 0.001) and had more post-COVID comorbidity (88.2% vs 60.0%; p < 0.001). In the multivariable model within long COVID cases (n = 85), active employment was independently associated with better HRQoL (B 5.315, 95% CI 0.610 to 10.021; p = 0.027), whereas depressive symptoms (B - 1.124, 95% CI - 1.500 to - 0.748; p < 0.001) and post-COVID comorbidity count (B - 1.252, 95% CI - 2.484 to - 0.021; p = 0.046) were independently associated with worse HRQoL. Fatigue severity showed a borderline association in the same direction (B - 0.171, 95% CI - 0.343 to + 0.001; p = 0.051). The model explained 48.9% of the variance in SF-12 score within long COVID cases (R

conclusionsLong COVID was associated with profound impairment in HRQoL compared with recovered controls. Depressive symptoms, post-COVID comorbidity burden, and lower active employment were the strongest independent correlates of poorer HRQoL; fatigue severity showed a borderline association in the same direction. These findings support multidisciplinary long COVID care models that integrate symptom control, mental health assessment, and social and occupational reintegration. Routine assessment of fatigue, depressive symptoms, post-COVID multimorbidity, and occupational status may help identify long COVID patients with the most severe concurrent HRQoL impairment, though longitudinal confirmation is needed to establish predictive utility.

trial registrationTrial registration: ISRCTN registry, identifier ISRCTN27312680.

Indexed as

COVID-19Quality of LifeAdultAgedCase-Control StudiesDepressionFatigueFemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromePrimary Health CareSleep QualitySymptom BurdenCluster analysisDepressionFatigueHealth-related quality of lifeLong COVIDPrimary careSF-12

Identifiers

PMID42343284
PMCPMC13595673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.